| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +582% |
| 3Y CAGR | +96% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +211% |
| 3Y CAGR | +108% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,359.70 +23.30 (1.00%) | 17,770.39 | 26.21 | 5.27 | ||
PfizerPFIZER | ₹3,714.10 +75.40 (2.07%) | 16,642.57 | 22.64 | 3.96 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,313.00 +21.50 (0.34%) | 15,708.13 | 92.61 | 18 | ||
Natco PharmaNATCOPHARM | ₹785.55 -0.20 (0.03%) | 15,419.78 | 13.47 | 1.47 |